Mid-Year Insurance Multi-Asset Outlook — Do the fundamental things apply?

Is there a disconnect between the market’s recent rally and the economic fundamentals? Tim Antonelli and Danny Cook offer their perspective and consider the investment implications in their mid-year outlook for insurers.

Views expressed are those of the authors and are subject to change. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional or institutional investors only.

Key points

  • Potential treatments/vaccines for COVID-19, policy support, and gradually reopening economies make us more comfortable adding risk over our 12-month time frame.
  • However, the market’s sharp rally and the prospect of a slow economic recovery leave us only moderately bullish on risk assets.
  • Within surplus assets, we prefer high-yield credit, bank loans, US equities, and growth and quality factors, though we think some value-oriented sectors are attractive near term.
  • Within reserve assets, we expect interest rates to stay low and find some areas of the securitized market attractive.
  • Downside risks include a second wave of COVID-19, a deeper and longer recession than anticipated, worsening US-China relations, and Brexit. Upside risks include reflation and US-dollar weakness.

GLOBAL EQUITY MARKETS HAVE STAGED A REMARKABLE REBOUND OVER THE PAST FEW MONTHS, retracing 73% of their COVID-19 decline as of June 22. The speed and magnitude of the risk rally is unprecedented relative to past economic shocks, so it’s understandable that investors are asking whether there’s a disconnect between the market gains and the economic fundamentals. In the short term, we think the market recovery is justified: Treatments and vaccines for COVID-19 are likely on the horizon, monetary and fiscal policy support is strong, and economies are slowly reopening (Figure 1).

However, after the initial burst of economic improvement from ultra-depressed levels, we expect a slower pace of recovery. In addition, since the fundamentals are dependent on the course of and treatments for a disease, and recovery from a unique and drastic shock, it’s difficult to have a high degree of confidence about the path of the global economy. Taking all of this into account, we think volatility will remain elevated over the next 6 – 12 months and have tilted our views only modestly in favor of more aggressive exposures, leaving us fairly neutral across asset classes.

We expect interest rates to stay low and find many areas of credit attractive. We believe the COVID-19 shock is deflationary and, consequently, think commodities could be a source of funds going forward. We continue to prefer US equities, given our expectation that global growth will recover slowly and to a weak level. We are neutral on European, Japanese, and emerging markets (EM) equities, as we think less attractive fundamentals are offset by cheaper valuations.

FIGURE 1

Fiscal and monetary support for a recovery

Credit: Have spreads come too far?

Like equities, credit has had an extraordinary run this past quarter, with spreads narrowing hundreds of basis points in many cases. Despite that, we believe spreads remain cheap. The US Federal Reserve’s (Fed’s) credit-purchase programs give us confidence that spreads could…

To read more, please click the download link below.

Recommended for you

Credit research looms large in the era of COVID-19
In the wake of severe credit-market dislocations earlier this year, Fixed Income Portfolio Manager Mahmoud El-Shaer shares his thoughts on the growing importance of credit research in a still-uncertain environment.
August 2020
Credit research looms large in the era of COVID-19
,
Where can insurers find compelling returns?
In our mid-year insurance webcast recap, we shed light on the early signs of recovery that we are observing and where they intersect favorably for insurers from an investment standpoint.
July 2020
Where can insurers find compelling returns?
,
Insurance summer reading list
Our culture values continuous learning, personal growth, and humility. Therefore, it has become a tradition that, each year, we poll our colleagues to ask for their latest reads to kick-start summer, a season when many of us seek time to reflect and recharge. Learn how our 2020 reading list is inspiring us.
July 2020
Insurance summer reading list
,
Insurers in the hot seat: Illiquidity, impairments, and <br>enterprise risk
Whether it's a financial meltdown, a natural catastrophe, or the COVID-19 pandemic, insurance companies often find themselves in the cross-hairs when a global crisis hits. Multi-Asset Insurance Strategist Tim Antonelli shares his thoughts on how insurers can navigate today's troubled landscape.
May 2020
Insurers in the hot seat: Illiquidity, impairments, and
enterprise risk
,
Insurance Multi-Asset Outlook — A game plan for insurers to navigate volatility
Multi-Asset Insurance Strategist Tim Antonelli and Investment Strategy Analyst Daniel Cook consider the economic impact of the ongoing COVID-19 virus and the implications for various asset classes.
April 2020
Insurance Multi-Asset Outlook — A game plan for insurers to navigate volatility
,
Five reasons to rethink your BOLI allocation
We explore several new opportunities offered by a more modern approach to BOLI portfolios.
March 2020
Five reasons to rethink your BOLI allocation
,
Value investing’s existential crisis
In this video series, Multi-Asset Strategist Adam Berger sits down with researchers and portfolio managers from across our equity and alternatives platforms to discuss the long stretch of underperformance by value stocks.
March 2020
Value investing's existential crisis
,
Debunking four common myths about CLOs
Fixed Income Portfolio Manager Alyssa Irving sets the record straight regarding the risks and potential benefits of investing in collateralized loan obligations (CLOs).
January 2020
Debunking four common myths about CLOs
,

We use cookies to improve your experience on our website. To accept cookies click Accept & Close, or continue browsing as normal. For more information, visit Cookies & Tracking NoticE.